Report #2836811

Received Apr 18, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: TX
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
MNQ	MENINGOCOCCAL CONJUGATE (MENVEO)	NOVARTIS VACCINES AND DIAGNOSTICS	UNK	UNK	—

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

Pharmacy shared they vaccinated patients over the age of 55; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate age at vaccine administration in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced inappropriate age at vaccine administration (Verbatim: Pharmacy shared they vaccinated patients over the age of 55). The outcome of the inappropriate age at vaccine administration was not applicable. Additional Information: GSK Receipt Date: 09-APR-2025 Pharmacy shared they vaccinated patients over the age of 55 that have compromised immune system and the claims were denied which led to Inappropriate age at vaccine administration.